企業プロフィール
Teleflex 株価・ニュース・カタリスト
- ティッカー:
- TFX
- 取引所:
- NYSE
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
126.11 USD (+0.86%)
終値
最終更新: 2026年10月1日
5.54B USD
時価総額
株価変動の要因
2026年10月1日 時点で TFX は 0.86% 上昇し、$126.11 で取引を終えました。現在のニュース監視期間内に同社の新しいニュースは確認されませんでした。
企業概要
Diversified Medical Technology Company
Teleflex develops medical devices used in vascular access, interventional cardiology and radiology, surgery, anesthesia, emergency medicine, and urology. Its portfolio includes established brands such as Arrow, QuikClot, LMA, Weck, Barrigel, and Rüsch.
Vascular and Emergency Medicine
The vascular business includes central venous access, arterial access, intraosseous access, hemostatic products, and emergency-care technologies. EZPLAZ freeze-dried plasma extends the portfolio into a biologic product intended for settings where conventional plasma may be unavailable.
Interventional Portfolio
Teleflex's interventional business includes coronary and peripheral devices, catheter-based technologies, and the acquired BIOTRONIK vascular intervention portfolio. These products are used by interventional cardiologists and radiologists in minimally invasive procedures.
Surgical Products
The surgical portfolio includes ligation, closure, specialty instruments, and other products used in operating rooms. Brands such as Weck and Deknatel provide recurring demand across a broad range of procedures.
Freesolve Resorbable Scaffold
Freesolve is a drug-eluting resorbable magnesium scaffold designed to provide temporary vessel support and then dissolve. The program includes completed long-term follow-up, an ex-U.S. randomized study, and a U.S. pivotal trial.
今後のカタリスト
- Late-2027 data readout from the randomized BIOMAG-II study of the Freesolve resorbable magnesium scaffold.
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。